Table 3.
Univariate analysis for predictors of cardiotoxicity.
| Odds Ratio | 95% CI | p-value | |
|---|---|---|---|
| Female Sex | 0.71 | 0.33–1.54 | 0.39 |
| Race or Ethnicity | |||
| Chinese | 0.50 | 0.24–1.04 | 0.06 |
| Malay | 1.19 | 0.47–3.01 | 0.71 |
| Indian | 0.27 | 0.03–2.05 | 0.21 |
| Others | 5.35 | 2.27–12.63 | <0.001 |
| Age at diagnosis, years | 1.02 | 0.95–1.08 | 0.56 |
| Follow-up duration | 1.01 | 0.95–1.08 | 0.62 |
| Cumulative doxorubicin equivalent dose | 1.00 | 0.99–1.00 | 0.23 |
| ≥250 mg/m2 | 1.61 | 0.77–3.36 | 0.20 |
| Radiation involving the heart | 1.37 | 0.39–4.74 | 0.62 |